HealthTree Logo HealthTree Foundation
Donate

Notifications

You're all caught up

HealthTree Logo
Donate
Personal Health Record
  • My Feed
  • Recently viewed

Learn

  • Topics
  • Events

Explore

  • Find treatments & trials
  • Participate in research
  • Find a coach
  • Find a specialist
  • Talk to a patient navigator
  • Get involved
  • For researchers
  • For healthcare providers
  • About us
  • Get involved
  • For researchers
  • For healthcare providers
  • About us

Create your Personal Health Record and unlock support built around you

Aligned with your diagnosis, treatment and where you are in your care. It lets HealthTree show you:

  • Treatments and trials you qualify for
  • Education for your stage of care
  • Financial support for your medications
  • Solutions to your side effects
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path
Learn more about HealthTree
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path
Video

BETA - What is meant by an "out of spec" CAR-T product?

Posted by
HealthTree Logo HealthTree
• April 4, 2026

Description

Learn from cancer experts what an "out of spec" CAR-T product is and how it affects patients.

On this video

Healthtree contact Craig Hofmeister, MD, MPH, Specialist

Craig Hofmeister, MD, MPH, Specialist

Winship Cancer Institute - Emory University

Healthtree contact Krina K. Patel, Specialist

Krina K. Patel, Specialist

MD Anderson Cancer Center

Related Content

  • Video Axi-Cel (Yescarta)-A CD19 Directed CAR-T Cell Product for Lymphoma
  • Event Understanding CAR T Therapy: A Guide for Lymphoma & CLL Patients
  • Video CD22-Directed CAR-T for Lymphoma: 92% Response, 85% Complete Remission #Lymphoma
  • News Does CAR T-Cell Therapy Cause Hair Loss?
  • News Does CAR T-cell Therapy Impact Thyroid Health?